Melatonin proves effective as anti-depressent among women with breast cancer

A study of the use of melatonin as an anti-depressent for patients with breast cancer has proved positive, according to an article in the  June 2014 Breast Cancer Research and Treatment Journal.

The study showed that "melatonin significantly reduced the risk of depressive symptoms in women with breast cancer during a three-month period after surgery."

Researchers undertook the study because depression, anxiety and sleep disturbances are known problems in patients with breast cancer and since the effect of melatonin as an antidepressant in humans with cancer had not been investigated.

"We investigated whether melatonin could lower the risk of depressive symptoms in women with breast cancer in a three-month period after surgery and assessed the effect of melatonin on subjective parameters: anxiety, sleep, general well-being, fatigue, pain and sleepiness," said Melissa V. Hansen, the lead investigator.

Randomized, double-blind, placebo-controlled trial undertaken from July 2011 to December 2012 at a department of breast surgery in Copenhagen, Denmark. Women, 30-75 years, undergoing surgery for breast cancer and without signs of depression on Major Depression Inventory (MDI) were included 1 week before surgery and received 6 mg oral melatonin or placebo for 3 months.

The primary outcome was the incidence of depressive symptoms measured by MDI. The secondary outcomes were area under the curve (AUC) for the subjective parameters. 54 patients were randomized to melatonin (n = 28) or placebo (n = 26) and 11 withdrew from the study (10 placebo group and 1 melatonin group, P = 0.002).

The risk of developing depressive symptoms was significantly lower with melatonin than with placebo (3 [11 %] of 27 vs. 9 [45 %] of 20; relative risk 0.25 [95 % CI 0.077-0.80]), giving a NNT of 3.0 [95 % CI 1.7-11.0]. No significant differences were found between AUC for the subjective parameters. No differences in side effects were found (P = 0.78).

Reference:

Melissa V Hansen, Lærke T Andersen, Michael T Madsen, Ida Hageman, Lars S Rasmussen, Susanne Bokmand, Jacob Rosenberg, & Ismail Gögenur. (2014, June).  Effect of melatonin on depressive symptoms and anxiety in patients undergoing breast cancer surgery: a randomized, double-blind, placebo-controlled trial. Breast Cancer Research and Treatment Journal. 145(3):683-95. Epub 2014 Apr 23. PMID: 24756186

'One Girl Wellness' Founder Offers Tips for Mindfulness, Self-Compassion, and Self-Love

Susan Bodiker

Susan Bodiker is a former 'fat girl' – and she will be the first one to tell you that. Like so many women, her body image issues started at a young age, and it didn't matter if she was at a weight of 120, 130, or 140 – she still saw a 'fat girl' staring back at her in the mirror. It was only when she learned to nourish her mind and heart first that she lost the weight and gained the confidence to create a meaningful, happy life – and she wants that to be every girl's story.

Bodiker founded One Girl Wellness, a health-coaching consultancy dedicated to "raising stronger women one girl at a time." She shares her journey and guidance for others to find that strength in her new book, Fat Girl: How to Let Go of Your Weight and Get on With Your Life, a roadmap to greater self-knowledge, self-awareness and self-esteem.

One Girl Wellness deals with topics including:

• What's Your Go-To Mantra? Rid yourself of negative, self-defeating mindsets and replace them with words to live by on a daily basis
• Mind Over Platter. Learn to become a more mindful, less distracted eater by living fully in the moment
• Stretching Hurts. And That's a Good Thing. Stretching pushes you through temporary discomfort to get to a better place - in other words, a way to become transformative
• How Does This Make You Feel? Women excel in dieting usually at the same rate they do self-loathing. The key to reversing that: Learning "body self-compassion"

About Susan Bodiker: 
With 30 years' experience as a copywriter, broadcast producer and account planner, Susan Bodiker has developed branding, image and fund-raising campaigns for advocacy, association, health care, nonprofit, professional practice and retail clients. She has also created print, broadcast and digital advertising, training materials and web content for a range of local and national marketers—from AARP to the YMCA. She is the founder of One Girl Wellness, a health-coaching consultancy dedicated to "raising stronger women one girl at a time".

Website: www.onegirlwellness.com; www.susan-bodiker.com
Fat Girl: How to Let Go of Your Weight and Get on With Your Life can be purchased from Amazon, Barnes & Noble and through all major booksellers.
Connect with Susan Bodiker on Facebook, LinkedIn, Twitter and GoodReads.

Irritable Bowel Syndrome (IBS)

 

PROBIOTICS OFFER A PROMISING SOLUTION FOR IRRITABLE BOWEL SYNDROME

Beltsville, MD, MARCH 2013 – April is Irritable Bowel Syndrome (IBS) Awareness Month.  IBS is a chronic condition affecting between 15 and 20 percent of all adults in the Western world. However, IBS is difficult to identify due to the numerous symptoms associated with it. Almost 40 percent of IBS sufferers report symptoms severe and frequent enough to disrupt their daily lives, making it is a serious issue.

IBS is not technically a disease but, rather, a series of symptoms, which can often be controlled with a various lifestyle changes, such as diet, stress reduction, hydration, an increase in dietary fiber and a healthy balance of intestinal microflora, which can be achieved by taking probiotic supplements.

IBS symptoms range from annoying to debilitating, causing severe constipation in some, to chronic diarrhea, bloating, gas, fatigue, heartburn and depression in others. Often IBS is diagnosed by exclusion—more often described by what it is not rather than what it is—which can lead to overuse of the term.  While the direct cause of IBS is unknown, most medical professionals agree it stems from dysfunction within the intestines1. For the estimated 54 million Americans that it affects—75 percent of them female—the solution often compounds the problem.

Many medical professionals believe that IBS symptoms can be mollified by a course of antibiotics aimed at eliminating bacterial overgrowth. However, antibiotics not only eliminate harmful bacteria, they attack essential and beneficial bacteria as well. While antibiotics may offer some quick relief, it's not a long-term solution. Reversing the effects of IBS can be a slow process, but with an integrated approach that includes an appropriate probiotic supplement, results can be encouraging and long lasting.
 
One such approach is taking probiotic supplements to restore the proper microbial environment in the GI tract. Once achieved, this will help minimize the number and severity of IBS symptoms. The type of probiotic strains used and the amount of viable CFUs (colony forming units) a probiotic supplement contains is critical in providing the most effective results.

About Vidazorb®

Vidazorb® represents a group of superior shelf-stable, chewable probiotic formulations that provide essential support for core health needs. Research and development, together with a commitment to quality and efficacy, defines Vidazorb® as a brand of integrity and excellence. For more information, visit www.Vidazorb.com. For engaging, kid-friendly probiotic information, visit www.Zorbee.com. To learn more about the importance of, and science supporting, probiotics, visit www.YouAreWhatYouAbsorb.com. 

Vidazorb® uses clinically substantiated strains from Chr. Hansen. In studies on Chr. Hansen L. acidophilus, LA-5® and Bifidobacterium, BB-12®, these strains have been shown to be effective in counteracting antibiotic side effects, treating diarrhea and constipation, and reducing stool frequency in those with collagenous colitis (CC), among other benefits2.

 

Why sleep is so important

Source: http://frugaldad.com